Vickers Top Insider Picks for May 26 2026 Key Transactions Signal Confidence Dell Shares Surge on AI Server Demand as Revenue Growth Accelerates Chinas APEC Trade Message Commerce Minister Skips Opening Amid Urgent Business Deputy Calls for Regional Cooperation Roundhill Memory ETF Surges 85 on Soaring Memory Chip Stocks Micron and Sandisk Quantum Computing Stocks Rally on 2 Billion US Government Funding Plan XOVR ETF Hyperscaler AI Capex in Focus Ahead of Summer 2026 Earnings FatPipe Inc Q1 2026 Earnings Positive EPS Reported Amidst Market Skepticism TTM Technologies Inc TTMI Q1 2026 Earnings EPS Beats Estimates by 991 Stock Rises 881 SLR Investment Corp SLRC Q1 2026 Earnings EPS Misses Estimates Amid Higher Expenses IIIN Q1 2026 Earnings EPS Misses Estimates as Steel Wire Demand Softens Stock Gains Despite Shortfall JetBlue Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Weigh on Results Biogen Q1 2026 Earnings Strong EPS Beat Drives PostMarket Rally Azenta Inc AZTA Gains 246 as Price Nears Key Resistance at 2205 Willow Lane Acquisition Corp II Unit WLIIU Edges Higher as Investors Eye Support Levels SuperCom Ltd SPCB Shows Modest Gains Amid Support Test Akari Therapeutics AKTX Plunges 126 Amid Heightened Biotech Volatility MillerKnoll Inc MLKN Sees Modest Gains as Shares Hold Above Key Support Level Telsey Advisory Group Highlights Lowes Resilient Execution Amid Housing Market Headwinds THRY Q1 2026 Earnings Significant EPS Surprise Drives Positive Stock Reaction HF Sinclair DINO Edges Higher Amid Steady Trading Holds Above Key Support Dutch Bros Inc BROS Gains 181 as Stock Holds Above Key Support Level ASE Technology Holding ASX Surges 665 as Semiconductor Sector Momentum Accelerates InvenTrust Properties Corp IVT Edges Higher as Price Holds Near 33 Support Zone FG Imperii Warrants FGIIW Hold Steady at 025 Key Levels in Focus FG Imperii Acquisition Corp FGII Holds Steady Near Trust Value as SPAC Investors Await Merger Catalyst GAVA Stakes Claim Near Resistance Avalanche ETF Climbs 122 Amid Volume Shift ADMA Biologics Reverses Lower Support Levels Tested After Recent Rally